Culture-independent bacterial population analysis - Clinical implications for respiratory and other infections

Current Respiratory Medicine Reviews

Volumn 4, Issue 1, 2008, Pages 35-39

  Lynch, Susan V ^a   Yang, Katherine ^a   Brodie, Eoin L ^c   MacDougall, Conan ^a   Anderson, Gary L ^c   Wiener Kronish, Jeanine P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

16S rRNA; Antimicrobial efficacy; Antimicrobial resistance; Culture independent; Microbial community

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTAZIDIME; IMIPENEM; RNA 16S;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIUM CULTURE; BACTERIUM DETECTION; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG MONITORING; HOSPITAL INFECTION; HUMAN; MICROARRAY ANALYSIS; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 39449112208     PISSN: 1573398X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339808783497837     Document Type: Review

References (39)

1. Paterson DL, Rice LB. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis 2003; 36(8): 1006-12.
2. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115(2): 462-74.
3. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244(5): 379-86.
4. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003; 36(11): 1418-23.
5. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111(3): 676-85.
6. MacArthur RD, Miller M, Albertson T, et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis. 2004; 38(2): 284-8.
7. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49(9): 3640-5.
8. Centers. A public health action plan to combat antimicrobial resistance. 2001.
9. World. WHO global strategy for containment of antimicrobial resistance. 2001.
10. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42 Suppl. 2: S82-9.
11. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41(6): 848-54.
12. Livermore DM. The threat from the pink corner. Ann Med 2003; 35(4): 226-34.
13. Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 2003; 47(5): 1672-80.
14. Obritsch MD, Fish DN, MacLaren R, Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004; 48(12): 4606-10.
15. McGowan JE, Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med 2006; 119(6 Suppl 1): S29-36; discussion S62-70.
16. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Internal Med 2005; 165(12): 1430-5.
17. Cazzola M, Matera MG, Noschese P. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance. Pulm Pharmacol Ther 2000; 13(6): 249-56.
18. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006; 103(3): 732-7.
19. Brodie EL, Desantis TZ, Joyner DC, et al. Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl Environ Microbiol 2006; 72(9): 6288-98.
20. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science (New York, NY. 2005; 308(5728): 1635-8.
21. Cottrell MT, Yu L, Kirchman DL. Sequence and expression analyses of Cytophaga-like hydrolases in a Western arctic metagenomic library and the Sargasso Sea. Appl Environ Microbiol 2005; 71(12): 8506-13.
22. Mincer TJ, Fenical W, Jan= PR. Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl Environ Microbiol 2005; 71(11): 7019-28.
23. Stevens H, Stubner M, Simon M, Brinkhoff T. Phylogeny of Proteobacteria and Bacteroidetes from oxic habitats of a tidal flat ecosystem. FEMS Microbiol Ecol 2005; 54(3): 351-65.
24. Timke M, Wang-Lieu NQ, Altendorf K, Lipski A. Community structure and diversity of biofilms from a beer bottling plant as revealed using 16S rRNA gene clone libraries. Appl Environ Microbiol 2005; 71(10): 6446-52.
25. Wang M, Ahme S, Jeppsson B, Molin G. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 2005; 54(2): 219-31.
26. Brodie EL, DeSantis TZ, Parker JP, Zubietta IX, Piceno YM, Andersen GL. Urban aerosols harbor diverse and dynamic bacterial populations. Proc Natl Acad Sci USA 2007; 104(1): 299-304.
27. Lin LH, Wang PL, Rumble D, et al. Long-term sustainability of a high-energy, low-diversity crustal biome. Science (New York, NY. 2006; 314(5798): 479-82.
28. DeSantis TZ, Brodie EL, Moberg JP, Zubieta IX, Piceno YM, Andersen GL. High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol 2007; 53(3): 371-83.
29. Morar P, Singh V, Makura, Z, et al. Differing pathways of lower airway colonization and infection according to mode of ventilation (endotracheal vs tracheotomy). Arch Otolaryngol Head Neck Surg 2002; 128(9): 1061-6.
30. Heggie AD, Bar-Shain D, Boxerbaum B, Fanaroff AA, O'Riordan MA, Robertson JA. Identification and quantification of ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr Infect Dis J 2001; 20(9): 854-9.
31. Feldman C, Kassel M, Cantrell J, et al. The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J 1999; 13(3): 546-51.
32. Flanagan JL, Brodie EL, Weng L, et al. Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Infect Dis. In. review.
33. Lewenza S, Visser MB, Sokol PA. Interspecies communication between Burkholderia cepacia and Pseudomonas aeruginosa. Can J Microbiol 2002; 48(8): 707-16.
34. Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 2005; 21: 319-46.
35. Burton JE, Oshota OJ, North E, et al. Development of a multipathogen oligonucleotide microarray for detection of Bacillus anthracis. Mol Cell Probes 2005; 19(5): 349-57.
36. Cleven BE, Palka-Santini M, Gielen J, Meembor S, Kronke M, Krut O. Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J Clin Microbiol 2006; 44(7): 2389-97.
37. Davignon L, Walter EA, Mueller KM, Barrozo CP, Stenger DA, Lin B. Use of resequencing oligonucleotide microarrays for identification of Streptococcus pyogenes and associated antibiotic resistance determinants. J Clin Microbiol 2005; 43(11): 5690-5.
38. Lin B, Wang Z, Vora GJ, et al. Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays. Genome Res 2006; 16(4): 527-35.
39. Wang Z, Daum LT, Vora GJ, et al. Identifying influenza viruses with resequencing microarrays. Emerg Infect Dis 2006; 12(4): 638-46.